InfuSystem Holdings, Inc. (INFU) |
|
7.68 -0.02 (-0.26%)
|
03-22 15:59 |
|
Open: |
7.7 |
Pre. Close: |
7.7 |
|
High:
|
7.81 |
Low:
|
7.56 |
|
Volume:
|
27,465 |
Market Cap:
|
160(M) |
|
|
|
Technical analysis |
as of: 2023-03-22 3:49:01 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 10.34 One year: 11.91 |
| Support: |
Support1: 6.67 Support2: 5.55 |
| Resistance: |
Resistance1: 8.85 Resistance2: 10.19 |
| Pivot: |
8.47  |
| Moving Average: |
MA(5): 7.28  MA(20): 8.71
MA(100): 8.97 MA(250): 8.67 |
| MACD: |
MACD(12,26): -0.7 Signal(9): -0.5 |
| Stochastic oscillator: |
%K(14,3): 27.6 %D(3): 17.8 |
| RSI: |
RSI(14): 34.5 |
| 52-week: |
High: 10.88 Low: 6.09 |
| Average Vol(K): |
3-Month: 45 (K) 10-Days: 67 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ INFU ] has closed above bottom band by 32.1%. Bollinger Bands are 180.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 5 days. This is a sign that the current trend might continue. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
7.85 - 7.89 |
7.89 - 7.92 |
|
Low:
|
7.04 - 7.08 |
7.08 - 7.12 |
|
Close:
|
7.63 - 7.7 |
7.7 - 7.76 |
|
Company Description |
|
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan. |
Headline News |
Wed, 22 Mar 2023
Negative Pressure Wound Therapy Market Projected to Reach 6.1 ... - Medgadget
Tue, 21 Mar 2023
Semler Scientific's Q4 Earnings Report Exceeds Expectations - Best Stocks
Sun, 19 Mar 2023
InfuSystem Holdings, Inc. (AMEX:INFU) Q4 2022 Earnings Call Transcript - Yahoo Finance
Wed, 15 Mar 2023
Earnings Flash (INFU) INFUSYSTEM HOLDINGS Posts Q4 Revenue $28.8M, vs. Street Est of $30.8M - Marketscreener.com
Wed, 15 Mar 2023
InfuSystem Announces Operational and Financial Results for Fourth ... - Business Wire
Tue, 08 Nov 2022
InfuSystem Holdings Inc. (INFU) Q3 2022 Earnings Call Transcript - Seeking Alpha
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: AMEX |
| Sector: Healthcare |
| Industry: Medical Instruments & Supplies |
| Shares Out. |
21 (M) |
| Shares Float |
16 (M) |
|
% Held by Insiders
|
4.9 (%) |
|
% Held by Institutions
|
68.4 (%) |
|
Shares Short
|
225 (K) |
|
Shares Short P.Month
|
177 (K) |
Stock Financials |
|
EPS
|
0.54 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0.23 |
|
EPS Est Next Year
|
0.28 |
|
Book Value (p.s.)
|
2.25 |
|
Profit Margin (%)
|
11.6 |
|
Operating Margin (%)
|
2.4 |
|
Return on Assets (ttm)
|
1.7 |
|
Return on Equity (ttm)
|
30.8 |
|
Qtrly Rev. Growth
|
5.6 |
|
Gross Profit (p.s.)
|
2.8 |
|
Sales Per Share
|
4.86 |
|
EBITDA (p.s.)
|
0.72 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
22 (M) |
|
Levered Free Cash Flow
|
8 (M) |
Stock Valuations |
|
PE Ratio
|
14.34 |
|
PEG Ratio
|
7 |
|
Price to Book value
|
3.44 |
|
Price to Sales
|
1.59 |
|
Price to Cash Flow
|
7.19 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
